The MBDA-based CVD risk score added significant information to this model, indicating that biomarker-based information in the MBDA-based CVD risk score, which represents RA inflammation, contributed prognostic information that was not captured by the seven clinically-based variables, which included CRP. The gene discussed is CRP; the disease is rheumatoid arthritis.